-
Acknowledgement to reviewers
-
Withstanding the test of time for patients in oncology clinical trials
-
Skin health in oncology: evidence-based skin care for cancer patients
-
Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation
-
Internet of Things–Enhanced Mathematical Oncology: Conceptual Framework for Adaptive Cancer Care Modeling
-
Enhancing Oncological Care for India's Aging Population: Addressing the Complex Needs of Older Adults With Cancer
-
Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease
-
AI-Enhanced Predictive Analytics to Optimize Tele-Oncology Implementation in Rural Settings: Scoping Review
-
Still human: Presence, oncology, and artificial intelligence
-
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts
-
Factor Structures of the Hospital Anxiety and Depression Scale in Cancer: Implications of Comprehensive Confirmatory Analysis on the German Version of the HADS in an Oncological Sample
-
Changes in Distress Screening and Information Reception Among Cancer Patients Following a Training for Oncology Nursing Staff: A Pilot Study
-
Optimal management of venous thromboembolism in adolescent and young adult oncology patients
-
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
-
Cardiovascular Symptom Tracking Among Patients With Cancer in Cardio-Oncology Care: Qualitative Study Using the Capability, Opportunity, Motivation–Behavior (COM-B) Framework
-
Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma
-
Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology
-
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
-
Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice
-
Multimodal management of hormonal and oncological progression in PTHrP-secreting pancreatic neuroendocrine tumours
-
Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology
-
The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?
-
Haematological and Oncological Training Therapy With Stationary Strength and Cardio Machines (HOT) in Routine Cancer Care: A 3‐Year Real‐World Evaluation of Acceptance, Feasibility, Safety, and Effects
-
Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice
